Jill S. Waibel

Dermatology

3683 S Miami Ave Ste 200
Miami, FL 33133

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

: Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum.

: Real-World Cases Using Phyto Polydeoxyribonucleotide (PDRN) Serum.

Journal: Journal of drugs in dermatology : JDD

Published: September 04, 2026

INDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With Hyperpigmentation.

INDIVIDUAL ARTICLE: Real World Use of Topical Tranexamic Acid Serum in Patients With Hyperpigmentation.

Journal: Journal of drugs in dermatology : JDD

Published: April 03, 2026

Clinical Age-reversal Quantification of a Facial Skincare Regimen with Sirtuin-targeting Ingredients in a Multiethnic Population.

Clinical Age-reversal Quantification of a Facial Skincare Regimen with Sirtuin-targeting Ingredients in a Multiethnic Population.

Journal: The Journal of clinical and aesthetic dermatology

Published: February 05, 2026

Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices.

Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices.

Journal: Journal of drugs in dermatology : JDD

Published: February 05, 2026

Review of Laser Therapy for Burn Injuries and Considerations for Burns in the Military Population.

Review of Laser Therapy for Burn Injuries and Considerations for Burns in the Military Population.

Journal: Journal of drugs in dermatology : JDD

Published: February 05, 2026

Astragalus membranaceus Extract as a Botanical Ingredient for Pigmentary and Anti-Aging Skincare: A Systematic Review.

Astragalus membranaceus Extract as a Botanical Ingredient for Pigmentary and Anti-Aging Skincare: A Systematic Review.

Journal: Journal of drugs in dermatology : JDD

Published: January 06, 2026

Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.

Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials.

Journal: Lancet (London, England)

Published: July 08, 2025

Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.

Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study.

Journal: American journal of clinical dermatology

Published: July 06, 2025

Comparative Efficacy of Dynamic and Contact Cooling With the Fifth-generation Pulsed Dye Laser for Breast Surgical Scars in Cancer Survivors.

Comparative Efficacy of Dynamic and Contact Cooling With the Fifth-generation Pulsed Dye Laser for Breast Surgical Scars in Cancer Survivors.

Journal: Plastic and reconstructive surgery. Global open

Published: June 27, 2025

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study.

Journal: Dermatology and therapy

Published: June 20, 2025

Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face.

Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face.

Journal: Lasers in surgery and medicine

Published: February 24, 2025

Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection.

Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection.

Journal: Journal of drugs in dermatology : JDD

Published: January 06, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026